DE-111A

· Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DE-111A, covering 2023-07-14 to 2023-07-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension [Phase 3]